Workforce Cuts Abound at Zealand Pharma, Merck and Orchard

Several employees at three biopharma firms are not having a very good week, as Zealand Pharma, Merck and Orchard Therapeutics all announced job cuts.

Denmark-headquartered Zealand Pharma announced that it is laying off 90% of its staff in the U.S. by the third quarter of 2022 as part of a huge corporate restructuring move to pursue more robust partnerships.